| Literature DB >> 32567037 |
Sri Hari Sundararajan1, Raphael Doustaly2, Gregoire Avignon2, David C Madoff3,4, Ronald S Winokur3,5.
Abstract
PURPOSE: Pre-procedural contrast-enhanced CT and MRI imaging is typically acquired prior to deep venous recanalization procedures for post-thrombotic syndrome. This technical note reports the utility of live-overlay of augmented centerlines extracted from pre-procedural CT and MRI imaging in facilitating fluoroscopic-guided recanalization of post-thrombotic venous lesions. METHODS AND MATERIALS: Six patients with pre-procedural CT or MR venography data were incorporated into a commercially available 3D overlay software (Vessel Assist, GE Healthcare, Buc, France) during venous disease interventions for post-thrombotic venous lesions. Procedures were performed on the GE Discovery IGS 740 fluoroscopy system. After manual determination of the vasculature from preprocedural CT or MR, centerlines were created representing the location and trajectory of the vessels. Steps showcasing the creation of centerlines and their representation during overlay with real-time fluoroscopic guidance in these cases are outlined. Time required to cross the post-thrombotic and occlusive venous segments were reviewed.Entities:
Keywords: Chronic venous occlusion; Fluoroscopic live overlay; Iliocaval thrombosis; Pre-procedural CT MR venography; Venous recanalization; Vessel ASSIST; Vessel overlay; Vessel tracking
Year: 2020 PMID: 32567037 PMCID: PMC7306479 DOI: 10.1186/s42155-020-00121-6
Source DB: PubMed Journal: CVIR Endovasc ISSN: 2520-8934
Fig. 1Centerline creation and roadmapping step-by-step tutorial. Begin by distinguishing bone, vessel and calcification densities from the pre-operative CT and start building the centerline for the vessels of interest using the reformatted views (a, white arrow on initial axial starting point). The centerline will start growing in 3D (b, white arrow). Once the occlusion is reached, start a bridge and deposit multiple points throughout the occluded vessel until the re-entry point (c-d) to continue growing the line (e). Adjust the vessel centerline using a dedicated tool (f). Repeat the operation on other vessels if necessary (g). Before proceeding with intra-procedural vessel selection, an assisting x-ray technologist fuses the pre-operative data on live fluoroscopic images using a Bi-View guided workflow all at tableside. Registration is performed by cross-referring fixed fluoroscopic landmarks (in this case, pelvic and spinal bones) with the same osseous landmarks on CT using only 2 fluoroscopic images approximately 50–60 degrees apart (in this case, RAO 15 (h) and LAO 40 (i). After initial registration, the vessel centerlines are displayed to the user (j), providing guidance to navigate the catheter compared to the standard fluoroscopy image (k). Dynamic adjustments to the registration are performed as needed by adjusting the red bony landmark overlays. Note that the occluded right common iliac vein (white arrow) and infrarenal inferior vena cava (black arrow) have already been crossed without contrast instillation using this technique
Fig. 2Screen grab from technologist’s monitor during center line creation from pre-procedural imaging on a patient with bilateral ilio-femoral occlusions. The centerlines are defined on each side from a point distal to the occlusion and proximal to the patent portion of the inferior vena cava
Fig. 3The following case is from a vascular intervention separate from the reported patient cohort (a). Specifically, this demonstrates the ability to use MR datasets in following vessel centerlines in a similar fashion as described in the Fig. 1 caption. The centerlines are first created (b). Bones are then semi-automatically segmented and registered to the fluoroscopy for further guidance (c)
Fig. 4Cohort patient number 6 with a right iliac vein stent that was used for initial registration instead of the bones (a). The registration accuracy was considered appropriate (b). Final DSA under large field of view showed complete recanalization and allowed final assessment of the registration accuracy (c)
Patient demographics and cohort-specific venous pathology with follow-up
| # | Age | Gender | Preprocedural Imaging | Time between Imaging and Procedure | Proximal Extent | Distal Extent | Pathology | Occlusive | Change between Imaging and Procedure? | Crossing | Follow-up (time and patient status) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 55 | F | CT abdomen/pelvis (90 s contrast delay) | 1 month | IVC (Below Filter) Occlusion | Bilateral Femoral Vein Occlusion | Metastatic ovarian carcinoma. IVC and iliac vein thromboses related to extrinsic compression and carcinoma-related hypercoagulability. | Yes | No | 4.2 | 1 year followup (no further visits), no recurrent occlusion, continued compression stockings |
| 2 | 52 | M | CT abdomen/pelvis (90 s contrast delay) | 3 months | IVC (Below Filter) Occlusion | CIV Confluence Occlusion; Bilateral CIV and EIV Stenosis | RLE provoked DVT in 2015 following lumbar spinal surgery. IVC filter placed. Course complicated by progression of thrombosis and post-thrombotic syndrome. | Yes | Yes, new occlusion below iliocaval confluence | 5.2 | 5 year followup, no recurrent ileocaval occlusion, continues daily Coumadin 2 mg for chronic scarring of bilateral femoroal-popliteal veins |
| 3 | 62 | M | MRI venogram abdomen/pelvis | 1 month | Left CIV Stenosis, Left EIV Occlusion | Left Popliteal Occlusion | Unprovoked LLE DVT in 2016. Subsequent post-thrombotic syndrome with femoral vein stenosis and occlusive popliteal vein stenosis. | Yes | Yes, progression of thrombosis to include left EIV (initially from CFV) | 3.0 | 2 year follow-up (no further visits), no recurrent iliac stenosis/occlusion. Persistent mid left femoral vein occlusion with post-thrombotic change, switched to Xarelto and Aspirin 81 mg daily |
| 4 | 54 | M | CT abdomen/pelvis (90 s contrast delay) | 4 months | Right EIV to CFV Confluence In-Stent Stenosis | Distal Right CFV Stenosis | Morbidly obese patient with pulmonary hypertension, sarcoidosis, and IVC narrowing. Prior stenting from intrahepatic IVC to iliac bifurcation in 2015. Multiple subsequent venoplasties and stent extensions for lower extremity symptomatic control. | Noa | N/A, diagnosis could not be made on CT | 1.6 | 4 year followup, no further stenting, decreased frequency of interval venoplasties (yearly instead of every 3–6 months) for mild stenoses at junction of proximal IVC and right common femoral vein constructs, continues Coumadin 3 mg and Aspirin 81 mg daily |
| 5 | 64 | F | CT abdomen/pelvis (90 s contrast delay | 1 month | IVC (Below Filter) Occlusion | Bilateral EIV Occlusion | Morbidly obese patient with history of breast carcinoma, positive lupus anticoagulant, and DVT/pulmonary embolism following gastric bypass in 2010 at outside hospital. IVC filter placed. Following transition of care to current institution, note made of progressed iliocaval thrombotic burden below filter with post-thrombotic syndrome. | Yes | No | 3.8 | 4 year followup, no recurrent occlusion, continuing daily Xarelto |
| 6 | 36 | M | CT abdomen/pelvis (90 s contrast delay) | 2 weeks | Left CIV In-Stent Occlusion | Left Femoral Vein | History of Factor V Leiden, May Thurner Syndrome, and multiple prior LLE extremity interventions. Rethrombosis of indwelling stents within the left CIV, EIV, and CFV. | Yes | No | 2.4 | 3 year followup, recurrent occlusion 1 year following initial procedure, subsequent thrombolysis and thrombectomy with repeat occlusion 1 year following this, no further interventions given low likelihood of recanalization, continues daily Aspirin 81 mg and Fondaparinux |
aGiven body habitus, patient comes for routine venoplasty of stents depending on symptoms